Product Pathways
BCP0001 GDC-0941
GDC-0941 is a potent inhibitor of PI3Kα, PI3Kβ, PI3Kδ and PI3Kγ ;10G in stock
BCP0027 BEZ235
Orally active PI3K tyrosine kinase inhibitor
BCP0102 PL-100
PL-100 is a novel HIV-1 protease inhibitor (PI) with a favorable cross-resistance profile and high genetic barrier.
BCP0070 LY 294002
LY 294002 has been shown to be a potent inhibitor of PI 3-kinase activity, acting as a competitive inhibitor for ATP binding site of the enzyme.
BCP0138 XL147
XL147 is a selective inhibitor of Class I PI3K isoforms.
BCP0144 ZSTK474
ZSTK474, a novel s-triazine derivative, binds to the ATP-binding site of Class I phosphatidylinositol 3-kinases (PI3K) and inhibits PI3K activity.
BCP0224 PX-866
PX-866 is a small-molecule wortmannin analogue inhibitor of the alpha, gamma, and delta isoforms of phosphoinositide 3-kinase (PI3K) with potential antineoplastic activity.
BCP0167 AS252424
AS-252424 is a novel, potent and selective inhibitor of PI3Kγ with IC50 of 33 nM.
BCP0169 BAG956
Potent, ATP-competitive and selective dual PI3K and PDK1 inhibitor.
BCP0170 NVP-BBD130
Orally potent and selective dual PI3K/mTOR inhibitor.
第一页 1 2 3 4 5 6 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.